Pacira BioSciences (PCRX) Gross Margin (2010 - 2026)
Pacira BioSciences (PCRX) posted Gross Margin of 77.05% for Q2 2026, down 0.39 percentage points from 77.43% a year earlier and down 2.43 percentage points from the prior quarter.
Powered by 
Analysis
Pacira BioSciences (PCRX) Gross Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Gross Margin at Pacira BioSciences was 79.21%, up 1.01 percentage points year-over-year; for FY2025, it was 79.39%, up 3.70 percentage points from FY2024.
- Annual Gross Margin has increased for three consecutive years, with a five-year change of +6.69 percentage points (FY2020 to FY2025).
- In prior years, Pacira BioSciences' Gross Margin was 75.69% in FY2024 (+3.05 pp), 72.64% in FY2023 (+2.53 pp), 70.11% in FY2022 (-3.99 pp) and 74.10% in FY2021 (+1.41 pp).
- The Q2 2026 figure stands as the lowest quarterly Gross Margin since Q3 2024.
- On a year-over-year basis, Gross Margin increased in six of the last eight quarters, with an average year-over-year change of +2.59 percentage points.
- The strongest year-over-year quarter for Gross Margin in the past five years was Q4 2023, with a gain of 9.69 percentage points; the weakest was Q4 2022, with a drop of 11.50 percentage points.
- According to Business Quant data, Gross Margin for the three prior quarters was 79.47% (Q1 2026), 79.53% (Q4 2025) and 80.91% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 68.19% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 74.74% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 73.54% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 78.02% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 83.60% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 72.04% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 79.76% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 72.78% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 85.33% |
| 10 | Pacira BioSciences | 1.01 Bn | 73.12 Mn | 148.24 Mn | 77.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 77.05% |
| Mar 31, 2026 | 79.47% |
| Dec 31, 2025 | 79.53% |
| Sep 30, 2025 | 80.91% |
| Jun 30, 2025 | 77.43% |
| Mar 31, 2025 | 79.69% |
| Dec 31, 2024 | 78.70% |
| Sep 30, 2024 | 76.95% |
| Jun 30, 2024 | 75.14% |
| Mar 31, 2024 | 71.63% |
| Dec 31, 2023 | 73.69% |
| Sep 30, 2023 | 75.75% |
| Jun 30, 2023 | 71.55% |
| Mar 31, 2023 | 69.43% |
| Dec 31, 2022 | 63.99% |
| Sep 30, 2022 | 69.74% |
| Jun 30, 2022 | 70.12% |
| Mar 31, 2022 | 77.17% |
| Dec 31, 2021 | 75.50% |
| Sep 30, 2021 | 72.87% |
API Access
Pacira BioSciences Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "PCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=PCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();